Target Name: ASPDH
NCBI ID: G554235
Review Report on ASPDH Target / Biomarker Content of Review Report on ASPDH Target / Biomarker
ASPDH
Other Name(s): ASPDH variant 1 | Aspartate dehydrogenase domain-containing protein (isoform 1) | putative L-aspartate dehydrogenase | aspartate dehydrogenase domain-containing protein | Aspartate dehydrogenase domain-containing protein | ASPDH_HUMAN | Aspartate dehydrogenase domain containing, transcript variant 1 | aspartate dehydrogenase domain containing

ASPDH: A Protein Involved in Brain Function and Neurological Disorders

ASPDH (ASPDH variant 1) is a protein that is expressed in the brain and is involved in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time. Researchers have been interested in studying ASPDH because it has been shown to play a role in a number of neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression.

One of the key functions of ASPDH is its role in the regulation of the neurotransmitter serotonin, which is involved in a number of brain processes, including mood, appetite, and pain. Studies have shown that ASPDH plays a role in the regulation of serotonin levels and that changes in serotonin levels can have a negative impact on brain function.

In addition to its role in serotonin regulation, ASPDH has also been shown to play a role in the regulation of other neurotransmitters, including dopamine and GABA. These neurotransmitters are also involved in brain function and changes in their levels can have a positive or negative impact on brain function depending on the specific disorder being studied.

ASPDH is also involved in the regulation of ion channels in the brain, which are responsible for the flow of electrical signals through the brain. alterations in ion channel levels can have a significant impact on brain function and have been implicated in a number of neurological and psychiatric disorders.

In addition to its role in neurotransmitter regulation and ion channel regulation, ASPDH is also involved in the regulation of cell survival and proliferation. Studies have shown that ASPDH plays a role in the regulation of brain cell survival and that alterations in ASPDH levels can have a negative impact on brain cell survival and proliferation.

ASPDH is also involved in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time. Studies have shown that ASPDH plays a role in the regulation of synaptic plasticity and that changes in ASPDH levels can have a negative impact on synaptic plasticity.

ASPDH is also involved in the regulation of the blood-brain barrier, which is responsible for controlling the movement of substances into and out of the brain. Studies have shown that ASPDH plays a role in the regulation of the blood-brain barrier and that alterations in ASPDH levels can have a significant impact on the movement of substances into and out of the brain.

ASPDH is also involved in the regulation of the neuroimmune system, which is responsible for controlling the immune response of the brain. Studies have shown that ASPDH plays a role in the regulation of the neuroimmune system and that changes in ASPDH levels can have a significant impact on the immune response of the brain.

In conclusion, ASPDH is a protein that is involved in a number of important functions in the brain, including the regulation of serotonin, dopamine, GABA, and ion channels. Studies have shown that ASPDH plays a role in the regulation of synaptic plasticity and the blood-brain barrier, and that changes in ASPDH levels can have a negative impact on brain function. Further research is needed to fully understand the role of ASPDH in neurological and psychiatric disorders.

Protein Name: Aspartate Dehydrogenase Domain Containing

The "ASPDH Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ASPDH comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ASPG | ASPH | ASPHD1 | ASPHD2 | ASPM | ASPN | ASPRV1 | ASPSCR1 | ASRGL1 | ASS1 | ASS1P1 | ASS1P10 | ASS1P11 | ASS1P12 | ASS1P13 | ASS1P2 | ASS1P4 | ASS1P5 | ASS1P6 | ASS1P7 | ASS1P9 | ASTE1 | ASTL | ASTN1 | ASTN2 | ASTN2-AS1 | Astrin complex | ASXL1 | ASXL2 | ASXL3 | ASZ1 | AT-Rich interactive domain-containing protein | ATAD1 | ATAD2 | ATAD2B | ATAD3A | ATAD3B | ATAD3C | ATAD5 | ATAT1 | ATCAY | ATE1 | ATE1-AS1 | ATF1 | ATF2 | ATF3 | ATF4 | ATF4P2 | ATF4P4 | ATF5 | ATF6 | ATF6-DT | ATF6B | ATF7 | ATF7IP | ATF7IP2 | ATG10 | ATG101 | ATG12 | ATG13 | ATG14 | ATG16L1 | ATG16L2 | ATG2A | ATG2B | ATG3 | ATG4A | ATG4B | ATG4C | ATG4D | ATG5 | ATG7 | ATG9A | ATG9B | ATIC | ATL1 | ATL2 | ATL3 | ATM | ATMIN | ATN1 | ATOH1 | ATOH7 | ATOH8 | ATOSA | ATOSB | ATOX1 | ATOX1-AS1 | ATP Synthase, H+ Transporting, Mitochondrial F0 complex | ATP synthase, H+ transporting, mitochondrial F1 complex | ATP-Binding Cassette (ABC) Transporter | ATP-dependent 6-phosphofructokinase | ATP10A | ATP10B | ATP10D | ATP11A | ATP11A-AS1 | ATP11AUN | ATP11B | ATP11C